Defining the Longitudinal Risk of CIN 3+ for <CIN 2 Colposcopy for Patients Referred With High-Grade Cytology.
In: Journal of lower genital tract disease, Jg. 28 (2024), Heft 1, S. 7-11
academicJournal
Zugriff:
Results: Among 4,168 women referred to colposcopy for ASC-H, HSIL, squamous cell carcinoma, or adenocarcinoma, the 3- and 5-year CIN3 incidence rates were 17.7%/20.0% no biopsy, 13.0%/15.1% negative biopsy, and 18.9%/20.0% low-grade squamous intraepithelial lesion (LSIL) biopsies. The 3- and 5-year incidences of invasive cancer were: 1.25%/1.68% no biopsy, 0.78%/1.04% negative biopsy, and 0%/0% LSIL biopsy. When the initial cytology was AGC/adenocarcinoma in situ (n = 944), the 3- and 5-year rates of CIN3 were 7.42%/8.39% no biopsy, 7.41%/9.26% negative biopsy, and 7.69%/7.69% LSIL biopsy. The invasive cancer rates were 1.12%/1.54% no biopsy, 0.46%/0.46% negative biopsy, and 0.0%/0.0% LSIL biopsy. By screening cytology, participants referred for HSIL had the highest 3- and 5-year rates of CIN3 (18.9% and 21%) compared with AGC (7.22%/8.28%) and ASC-H (15.5%/18%). The 3- and 5-year invasive cancer rates were 1.38%/1.75% HSIL, 0.85%/1.17% AGC, and 0.91%/1.36% ASC-H.
Competing Interests: The authors have declared they have no conflicts of interest.
(Copyright © 2023, ASCCP.)
Titel: |
Defining the Longitudinal Risk of CIN 3+ for <CIN 2 Colposcopy for Patients Referred With High-Grade Cytology.
|
---|---|
Autor/in / Beteiligte Person: | Piedimonte, S ; Tsang, K ; Jembere, N ; Murphy, J ; Karapetian, T ; Gao, J ; McCurdy, B ; Sacco, J ; Kupets, R |
Zeitschrift: | Journal of lower genital tract disease, Jg. 28 (2024), Heft 1, S. 7-11 |
Veröffentlichung: | 2002- : Hagerstown, MD : Lippincott Williams & Wilkins ; <i>Original Publication</i>: Malden, MA : Blackwell Science Inc., c1997-, 2024 |
Medientyp: | academicJournal |
ISSN: | 1526-0976 (electronic) |
DOI: | 10.1097/LGT.0000000000000765 |
Schlagwort: |
|
Sonstiges: |
|